STOCKHOLDERS’ EQUITY (Tables)

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

SCHEDULE OF OUTSTANDING WARRANTS AND STOCK OPTION

Summary of Outstanding Warrants

	Number Outstanding		Exercisable		Weighted Average Remaining Term		Classification
Instrument:
Strategic Advisor Warrants		9,917,844		9,917,844		6.4	Equity
Placement Agent Warrants		3,855,822		3,855,822		4.4	Equity
Pre-Funded Warrants		6,646,855		6,646,855		n/a	Equity
Total outstanding		20,420,521

SCHEDULE OF CHANGES IN WARRANT ACTIVITY

The changes in the warrant activity for the period from January 1, 2026 through March 31, 2026 consisted of the following:

	Number of Warrants		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding, January 1, 2026		20,420,521	$	1.182		6.1		11,492,312
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited / Expired		-		-		-		-
Outstanding, March 31, 2026		20,420,521	$	1.182		5.9	$	6,174,928
Exercisable, March 31, 2026		20,420,521	$	1.182		5.9	$	6,174,928
Vested and expected to vest, March 31, 2026		20,420,521	$	1.182		5.9	$	6,174,928

SCHEDULE OF NONVESTED WARRANTS SUBJECT TO SERVICE-BASED VESTING CONDITIONS

A summary of the status of nonvested warrants subject to service-based vesting conditions as of and for the three months ended March 31, 2026 is presented below:

	Warrant Activity
	Number of Units			Weighted-Average Grant-Date Fair Value
Nonvested, January 1, 2026		9,917,844		$	1.752
Granted		-			-
Vested		(9,917,844	)		(1.752	)
Forfeited		-			-
Nonvested, March 31, 2026		-		$	-

SCHEDULE OF CHANGES IN STOCK OPTION

The changes in the stock option activity for the period from January 1, 2026 through March 31, 2026 consisted of the following:

	Number of Options		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding, January 1, 2026		-	$	-		-		-
Granted		6,500,000		1.01		10.0		-
Exercised		-		-		-		-
Forfeited / Expired		-		-		-		-
Outstanding, March 31, 2026		6,500,000	$	1.01		10.0	$	-
Exercisable, March 31, 2026		-	$	-		-	$	-
Vested and expected to vest, March 31, 2026		6,500,000	$	1.01		10.0	$	-

SCHEDULE OF NON-VESTED STOCK UNIT ACTIVITY

	Stock Option Activity
	Number of Units		Weighted-Average Grant-Date Fair Value
Nonvested, January 1, 2026		-	$	-
Granted		6,500,000		1.01
Vested		-		-
Forfeited		-		-
Nonvested, March 31, 2026		6,500,000	$	1.01

SCHEDULE OF RESTRICTED STOCK UNIT ACTIVITY

	Restricted Stock Unit Activity
	Number of Units			Weighted-Average Grant-Date Fair Value
Nonvested, January 1, 2026		400,000		$	1.46
Granted		-			-
Vested		(400,000	)		1.46
Forfeited		-			-
Nonvested, March 31, 2026		-		$	-

SCHEDULE OF DISAGGREGATED BREAKDOWN OF STOCK COMPENSATION EXPENSE

	Fair Value		Prior Expensed		For the Three Months Ended March 31, 2026			Unrecognized Expense
Instrument:
Strategic Advisor Warrants	$	11,533,125	$	7,688,800	$	3,844,325		$	-
Restricted Stock		1,250,000		416,667		833,333			-
Stock Options – Former Chairman of Board		273,299		273,299		(273,299	)		-
Restricted Stock Units		584,000		389,333		194,667			-
Stock Issuance		473,000		-		473,000			-
Stock Options		4,139,717		-		69,045			4,070,672
Total	$	18,253,141	$	8,768,099	$	5,141,071		$	4,070,672